Webster Financial ‘Avoided The Mistakes Of US Bank Failures’

The US financial sector is not without its problems but Ravi Chopra backs Webster Financial Corporation as his stock pick for the 2023 Sohn Hearts & Minds Investment Leaders Conference.
Azora Capital founder Ravi Chopra. Picture: Renee Nowytarger

David Rogers

Webster Financial ‘Avoided The Mistakes Of US Bank Failures’

November 17, 2023
The US financial sector is not without its problems but Ravi Chopra backs Webster Financial Corporation as his stock pick for the 2023 Sohn Hearts & Minds Investment Leaders Conference.
Read Transcript

The US financial sector is not without its problems but Ravi Chopra backs Webster Financial Corporation as his stock pick for the 2023 Sohn Hearts & Minds Investment Leaders Conference.

‍The chief executive and founder of US financial services hedge fund Azora Capital, did make a ton of cash for his clients by short selling each of the four US regional banks that failed in March.

‍In fact the hedge fund had its most profitable month on record.

‍But Webster Financial didn’t make the same mistakes as its peers, according to Mr Chopra.

‍Most US banks were sucked into buying low-interest rate, long-duration, fixed-rate assets at record lows, after the Federal Reserve slashed interest rates to record lows at the start of the Covid-19 pandemic.

‍That exposed them to a serious amount of interest rate risk which was triggered in 2022 when the Fed unleashed its most aggressive interest rate tightening since the 1970s.

‍But unlike the vast majority of its peers, Webster Financial has best-in-class capital and profitability.

‍It is also expected to trade on six times earnings per share for the next year and, most importantly, it has what Mr Chopra considers to be an “undervalued and underappreciated asset”.

‍Webster’s HSA Bank is the fourth largest provider of “health” savings accounts in the US.

‍While healthcare is notoriously expensive in the US, and one way that Americans offset that is by contributing — tax-free — towards their health savings accounts for medical expenses.

‍Because of contributions from monthly paychecks, HSA Bank’s business is “highly atypical, recurring, and grows in all environments”, including 2022 and 2023, when the rest of the banking industry saw its core deposits fall by over 20 per cent, Mr Chopra said.

‍Most of its peers bought 1.5 per cent yielding on paper, with 15-year maturities, at the lowest point of the Fed funds rate in the history of the United States, he recalled.

‍“None of them had any credit risk, but they sure had a whole lot of interest rate risk,” he said.

‍“Of course, that was in time for the Fed to raise rates 525 basis points in a straight line, which had two important impacts.

‍“One was that all those bonds were now $US7.3bn underwater, which for context is 16 per cent of bank capital, which is pretty similar to how credit losses were during the GFC.

‍“The second impact was that with higher interest rates, deposits started leaving the banking system and depositors started seeking higher yielding alternatives.”

‍Because US deposits above $US250,000 are uninsured, the failure of Silicon Valley Bank awakened uninsured depositors to the realisation that they were effectively unsecured lenders to banks, and not even getting paid to do so, causing deposit flight.

‍The other aspect of Webster’s business is that its deposits are “highly transactional.”

‍“So irrespective of the interest rate environment, HSA Bank pays a fixed 50 basis points on that cash,” Mr Chopra explained.

‍“So while we’ve raised the Fed funds rate to almost 5.5 per cent, the value of those deposits and therefore the value of that business has never been greater.”

‍He sees this an opportune time for Webster to monetise the strength of HSA Bank, either through a joint venture or an outright sale in business.

‍“Currently there’s a pure-play, publicly traded player in the HSA business which trades at 30 times earnings, due to all the great characteristics we just talked about.

‍“If we can cut that in half and use 15 times on HSA Bank and nine times on the rest of core Webster, which is a 20 per cent discount to its historical multiple, we get 60 per cent upside to stock price.

‍“So in summary, we believe that Webster Financial Corporation has a unique path to value creation for the monetisation picture, relative to the US banking industry that faces many, many challenges.”

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

The US financial sector is not without its problems but Ravi Chopra backs Webster Financial Corporation as his stock pick for the 2023 Sohn Hearts & Minds Investment Leaders Conference.

‍The chief executive and founder of US financial services hedge fund Azora Capital, did make a ton of cash for his clients by short selling each of the four US regional banks that failed in March.

‍In fact the hedge fund had its most profitable month on record.

‍But Webster Financial didn’t make the same mistakes as its peers, according to Mr Chopra.

‍Most US banks were sucked into buying low-interest rate, long-duration, fixed-rate assets at record lows, after the Federal Reserve slashed interest rates to record lows at the start of the Covid-19 pandemic.

‍That exposed them to a serious amount of interest rate risk which was triggered in 2022 when the Fed unleashed its most aggressive interest rate tightening since the 1970s.

‍But unlike the vast majority of its peers, Webster Financial has best-in-class capital and profitability.

‍It is also expected to trade on six times earnings per share for the next year and, most importantly, it has what Mr Chopra considers to be an “undervalued and underappreciated asset”.

‍Webster’s HSA Bank is the fourth largest provider of “health” savings accounts in the US.

‍While healthcare is notoriously expensive in the US, and one way that Americans offset that is by contributing — tax-free — towards their health savings accounts for medical expenses.

‍Because of contributions from monthly paychecks, HSA Bank’s business is “highly atypical, recurring, and grows in all environments”, including 2022 and 2023, when the rest of the banking industry saw its core deposits fall by over 20 per cent, Mr Chopra said.

‍Most of its peers bought 1.5 per cent yielding on paper, with 15-year maturities, at the lowest point of the Fed funds rate in the history of the United States, he recalled.

‍“None of them had any credit risk, but they sure had a whole lot of interest rate risk,” he said.

‍“Of course, that was in time for the Fed to raise rates 525 basis points in a straight line, which had two important impacts.

‍“One was that all those bonds were now $US7.3bn underwater, which for context is 16 per cent of bank capital, which is pretty similar to how credit losses were during the GFC.

‍“The second impact was that with higher interest rates, deposits started leaving the banking system and depositors started seeking higher yielding alternatives.”

‍Because US deposits above $US250,000 are uninsured, the failure of Silicon Valley Bank awakened uninsured depositors to the realisation that they were effectively unsecured lenders to banks, and not even getting paid to do so, causing deposit flight.

‍The other aspect of Webster’s business is that its deposits are “highly transactional.”

‍“So irrespective of the interest rate environment, HSA Bank pays a fixed 50 basis points on that cash,” Mr Chopra explained.

‍“So while we’ve raised the Fed funds rate to almost 5.5 per cent, the value of those deposits and therefore the value of that business has never been greater.”

‍He sees this an opportune time for Webster to monetise the strength of HSA Bank, either through a joint venture or an outright sale in business.

‍“Currently there’s a pure-play, publicly traded player in the HSA business which trades at 30 times earnings, due to all the great characteristics we just talked about.

‍“If we can cut that in half and use 15 times on HSA Bank and nine times on the rest of core Webster, which is a 20 per cent discount to its historical multiple, we get 60 per cent upside to stock price.

‍“So in summary, we believe that Webster Financial Corporation has a unique path to value creation for the monetisation picture, relative to the US banking industry that faces many, many challenges.”

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Nov 17, 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍Eminence Capital founder Ricky Sandler in Sydney. Picture: John Feder‍
November 6, 2024

Why this New York hedge fund manager sees opportunity in European stocks

Influential New York-hedge fund manager Ricky Sandler will turn to Europe for his next stock pick.

Read More
Vihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie DouvisVihari Ross of Antipodes. Picture: Louie Douvis
November 5, 2024

Antipodes’ Ross says short-term wealth hinges on US election

The portfolio manager says defensive stocks pose a bigger risk than the magnificent seven for investors that are overexposed to the American sharemarket.

Read More
Antipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John FederAntipodes Partners portfolio manager Vihari Ross: ‘We ask where the overvaluation is and where the opportunity is.’ Picture: John Feder
November 5, 2024

Concentration risk key for investors: Antipodes Partners’ Vihari Ross

The concentration risk in global stock indexes that has built up during the strong rise over the past year must now be a key consideration for global investors, according to Vihari Ross.

Read More
JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.JO Hambro Asset Management senior portfolio manager Samir Mehta.
November 5, 2024

The fundie betting big on China – with help from AI

Mr Mehta is sticking to his well-worn strategy: he’s hunting for companies across Asia that aren’t battling intense competition and have management teams focused on costs, cash generation and high payouts to shareholders.

Read More
Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.Beeneet Kothari is ready to shock the Sohn Hearts & Minds event.
October 29, 2024

Why this fundie wants you to ‘wince’ at his stock picks

When fund managers come to pitch their favourite stock at the annual Sohn Hearts & Minds conference, there are two ways they can go: they can play it safe, or they can take a risk and shock the room.

Read More
October 27, 2024

IFM Investors’ Rikki Bannan backs small cap investments to rebound after mixed performance

IFM Investors executive director Rikki Bannan believes this year could be a good one to invest in some select small cap stocks.

Read More
October 22, 2024

Meet the 2024 Conference Managers

Following a global search, the Conference Fund Manager Selection Committee is pleased to share eleven new managers for 2024.

Read More
October 21, 2024

Chris Kourtis is on a winning streak. Here’s his next ASX pick

Chris Kourtis of Ellerston Capital thinks he’s found another winner and thinks it’s the last chance to have a bite at the cherry before the strategy plays out.

Read More
Ellerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta CampionEllerston Capital portfolio manager Chris Kourtis. Picture: Britta Campion
October 21, 2024

Why Ellerston Capital’s Chris Kourtis plans to back a ‘hated’ stock

Chris Kourtis of Ellerston Capital plans to tip one of the “most hated” stocks in Australia when he presents at the 2024 Sohn Hearts & Minds Conference.

Read More
 ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion ‘We’re riding a wave which started (with) the first silicon chips,’ Alex Pollak says. Picture: Britta Campion
October 14, 2024

Alex Pollak champions rewards of disruptive investment

Alex Pollak’s funds management company Loftus Peak rode the Nvidia wave and he is now looking at more opportunities in disruptive industry stocks.

Read More
October 8, 2024

Sumit Gautam - Why AI won't deliver in 2025 | Scalar Gauge

Sumit Gautam is the Founder of Scalar Gauge and speaks with Equity Mates ahead of his appearance at the Sohn Hearts & Minds conference.

Read More
September 30, 2024

Missed out on Nvidia and Ozempic? This fundie says it’s never too late

Northcape Capital’s Fleur Wright is still kicking herself for not owning market darlings Nvidia and Novo Nordisk, the maker of the weight loss wonder drug Ozempic, before shares of those companies rocketed in 2023.

Read More
September 23, 2024

Scalar Gauge Fund founder Sumit Gautam cautious about over-hyped AI

Tech investor Sumit Gautam carefully avoids the word bubble when describing the investor frenzy surrounding the rise of artificial intelligence, but warns there are dangers of getting caught up in the hype.

Read More
September 9, 2024

The Wellcome Trust’s Nick Moakes made a 100-year bet. It’s paying off

Chief Investment Officer, Nick Moakes raised almost $3 billion at ultra-low rates. Sometimes the long view can be the most profitable.

Read More
Wellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven PocockWellcome Trust chief investment officer Nicholas Moakes. Picture: Steven Pocock
September 5, 2024

Honesty the only policy that matters, says Wellcome Trust’s Nicholas Moakes

The chief investment officer of the London-based $71bn Wellcome Trust, Nick Moakes, has a simple rule for the trust’s investment team: “Never invest with anyone who is or has been or should have been in prison.”

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.